» Articles » PMID: 6548132

Human Plasma Alpha-cysteine Proteinase Inhibitor. Purification by Affinity Chromatography, Characterization and Isolation of an Active Fragment

Overview
Journal Biochem J
Specialty Biochemistry
Date 1984 Jul 15
PMID 6548132
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Human plasma alpha-cysteine proteinase inhibitor (alpha CPI) was purified by a two-stage method: affinity chromatography on S-carboxymethyl-papain-Sepharose, and high-resolution anion-exchange chromatography. The protein was obtained as a form of Mr about 64 000 and material of higher Mr (about 100 000). In sodium dodecyl sulphate/polyacrylamide-gel electrophoresis with reduction, both forms showed a major component of Mr 64 000. An antiserum was raised against alpha CPI, and 'rocket' immunoassays showed the mean concentration in sera from 19 individuals to be 35.9 mg/dl. Both low-Mr and high-Mr forms of alpha CPI were confirmed to be sialoglycoproteins by the decrease in electrophoretic mobility after treatment with neuraminidase. alpha CPI was shown immunologically to be distinct from antithrombin III and alpha 1-antichymotrypsin, two serine proteinase inhibitors from plasma with somewhat similar Mr values. alpha CPI was also distinct from cystatins A and B, the two intracellular low-Mr cysteine proteinase inhibitors from human liver. Complexes of alpha CPI with papain were detectable in immunoelectrophoresis, but dissociated to free enzyme and intact inhibitor in sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. The stoichiometry of binding of papain was close to 1:1 for both low-Mr and high-Mr forms. alpha CPI was found to be a tight-binding inhibitor of papain and human cathepsins H and L (Ki 34 pM, 1.1 nM and 62 pM respectively). By contrast, inhibition of cathepsin B was much weaker, Ki being about 35 microM. Dipeptidyl peptidase I also was weakly inhibited. Digestion of alpha CPI with bromelain gave rise to an inhibitory fragment of Mr about 22 000, which was isolated.

Citing Articles

Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Kaplan A, Joseph K, Shibayama Y, Nakazawa Y, Ghebrehiwet B, Reddigari S Clin Rev Allergy Immunol. 1999; 16(4):403-29.

PMID: 9926288 DOI: 10.1007/BF02737659.


High-affinity binding of two molecules of cysteine proteinases to low-molecular-weight kininogen.

Turk B, Stoka V, BJORK I, Boudier C, Johansson G, Dolenc I Protein Sci. 1995; 4(9):1874-80.

PMID: 8528085 PMC: 2143202. DOI: 10.1002/pro.5560040922.


Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.

Hall A, Dalboge H, Grubb A, Abrahamson M Biochem J. 1993; 291 ( Pt 1):123-9.

PMID: 8471031 PMC: 1132490. DOI: 10.1042/bj2910123.


Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.

Pol E, Olsson S, Estrada S, Prasthofer T, BJORK I Biochem J. 1995; 311 ( Pt 1):275-82.

PMID: 7575465 PMC: 1136149. DOI: 10.1042/bj3110275.


Human liver cathepsin L.

Mason R, Green G, Barrett A Biochem J. 1985; 226(1):233-41.

PMID: 3977867 PMC: 1144697. DOI: 10.1042/bj2260233.


References
1.
Henderson P . A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J. 1972; 127(2):321-33. PMC: 1178592. DOI: 10.1042/bj1270321. View

2.
WILKINSON G . Statistical estimations in enzyme kinetics. Biochem J. 1961; 80:324-32. PMC: 1244002. DOI: 10.1042/bj0800324. View

3.
Barrett A . Chicken alpha2-proteinase inhibitor: a serum protein homologous with ovoinhibitor of egg white. Biochim Biophys Acta. 1974; 371(1):52-62. DOI: 10.1016/0005-2795(74)90154-8. View

4.
Sasaki M, Minakata K, Yamamoto H, Niwa M, Kato T, Ito N . A new serum component which specifically inhibits thiol proteinases. Biochem Biophys Res Commun. 1977; 76(3):917-24. DOI: 10.1016/0006-291x(77)91589-3. View

5.
Baines B, Brocklehurst K . A necessary modification to the preparation of papain from any high-quality latex of Carica papaya and evidence for the structural integrity of the enzyme produced by traditional methods. Biochem J. 1979; 177(2):541-8. PMC: 1186404. DOI: 10.1042/bj1770541. View